Veradermics MANE Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Veradermics in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: Veradermics ’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Veradermics 's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Veradermics 's accrued expenses?
- Veradermics (MANE) reported accrued expenses of $47K in Q4 2025.
- What does accrued expenses mean?
- Expenses that have been incurred but not yet paid or invoiced.
- How do you interpret accrued expenses?
- An increase often reflects growing operational activity or the timing of recurring costs like clinical trial expenses.
- How does accrued expenses compare across companies?
- Standard across all industries; biotech firms frequently have high accruals related to ongoing clinical research and development activities.